These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30147363)

  • 21. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of miR-421 predicts poor prognosis and promotes proliferation, migration, and invasion of papillary thyroid cancer cells.
    Dong A; Zhang J; Sun W; Hua H; Sun Y
    J Chin Med Assoc; 2020 Nov; 83(11):991-996. PubMed ID: 32881717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2.
    Wang LL; Zhang M
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7760-7767. PubMed ID: 30536321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
    Sun B; Liu HF; Ding Y; Li Z
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis.
    Wang T; Liu X; Tian Q; Liang T; Chang P
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3592-3597. PubMed ID: 28925485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low LINC01272 predicts poor prognosis of non-small cell lung cancer and its biological function in tumor cells by inhibiting miR-1303.
    Zhang S; Zhou J
    Oncol Lett; 2021 Sep; 22(3):652. PubMed ID: 34386074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway.
    Li C; Zhang J; Ma Z; Zhang F; Yu W
    Onco Targets Ther; 2018; 11():4087-4095. PubMed ID: 30038508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
    Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
    Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
    Liu XG; Zhu WY; Huang YY; Ma LN; Zhou SQ; Wang YK; Zeng F; Zhou JH; Zhang YK
    Med Oncol; 2012 Jun; 29(2):618-26. PubMed ID: 21516486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-4284 Promotes Cell Proliferation, Migration, and Invasion in Non-Small Cell Lung Cancer Cells and is Associated with Postoperative Prognosis.
    Yang H; Zhang W; Luan Q; Liu Y
    Cancer Manag Res; 2021; 13():5865-5872. PubMed ID: 34349559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.
    Han L; Zhang G; Zhang N; Li H; Liu Y; Fu A; Zheng Y
    Med Oncol; 2014 Sep; 31(9):129. PubMed ID: 25064732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-1225-5p inhibits non-small cell lung cancer cell proliferation, migration and invasion, and may be a prognostic biomarker.
    Li B; Zhang F; Li H
    Exp Ther Med; 2020 Dec; 20(6):172. PubMed ID: 33101465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin.
    Zhang J; Xu L; Yang Z; Lu H; Hu D; Li W; Zhang Z; Liu B; Ma S
    Clin Transl Oncol; 2015 Mar; 17(3):209-14. PubMed ID: 25214146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Circulating miR-762 as a Novel Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer.
    Chen L; Li Y; Lu J
    Technol Cancer Res Treat; 2020; 19():1533033820964222. PubMed ID: 33317398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance.
    Shi YK; Zang QL; Li GX; Huang Y; Wang SZ
    J Cancer Res Ther; 2016; 12(2):693-8. PubMed ID: 27461635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.
    Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM
    Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer.
    Wang J; Wang L; Zhang C
    Onco Targets Ther; 2021; 14():4335-4343. PubMed ID: 34376998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.